EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

C-Reactive Protein-to-Albumin Ratio in Pediatric Inflammatory Bowel Disease: Associations with Disease Activity and Comparison with C-Reactive Protein Alone

Jihye Kim, You Ie Kim iD, Sang Yong Kim

Diagnostics · 17.08.2026 · 16 (16) · 2608

DOI: 10.3390/diagnostics16162608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 17.08.2026. Verfasst von Jihye Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 2143…. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The C-reactive protein-to-albumin ratio (CAR) is an emerging biomarker of disease activity in adult inflammatory bowel disease; pediatric data remain limited. We evaluated CAR in pediatric Crohn’s disease (CD) versus ulcerative colitis (UC).

Methods

We retrospectively reviewed 97 consecutive pediatric patients (79 CD, 18 UC) diagnosed at a single center between 2012 and 2023.

Results

CAR was higher in CD (median 10.06) than UC (0.49; p < 0.001). In CD, CAR correlated with erythrocyte sedimentation rate, fecal calprotectin, and clinical and endoscopic disease activity (all p < 0.05), differed across severity categories (p = 0.001 clinical, p = 0.003 endoscopic), and was higher without perianal disease (p = 0.005); the corresponding analyses in UC (n = 18) were underpowered and did not reach significance. Receiver operating characteristic analysis yielded an area under the curve (AUC) of 0.840 (cut-off 1.62; sensitivity 86.1%, specificity 72.2%), not exceeding that of CRP alone (AUC 0.851; DeLong p = 0.090). CAR decreased significantly from diagnosis to one-year follow-up in both remission and relapse groups (both p < 0.001).

Conclusions

CAR reflects disease severity in pediatric CD and responds to treatment, but did not outperform CRP alone for distinguishing CD from UC. Its plausible value lies in activity assessment and serial monitoring rather than in diagnostic discrimination, a hypothesis that the present design cannot test.

Schlagwörter

Stichwörter der Autor:innen

C-reactive protein-to-albumin ratioCrohn’s diseasebiomarkerdisease activityinflammatory bowel diseasepediatricsulcerative colitis

Autor:innen und Institutionen

  • Department of Pediatrics, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Republic of Korea.

ORCID-Profile: You Ie Kim

Zitieren

APA

Kim, J., Kim, Y. I., & Kim, S. Y. (2026). C-Reactive Protein-to-Albumin Ratio in Pediatric Inflammatory Bowel Disease: Associations with Disease Activity and Comparison with C-Reactive Protein Alone. Diagnostics, 16(16), 2608. https://doi.org/10.3390/diagnostics16162608

Vancouver

Kim J, Kim YI, Kim SY. C-Reactive Protein-to-Albumin Ratio in Pediatric Inflammatory Bowel Disease: Associations with Disease Activity and Comparison with C-Reactive Protein Alone. Diagnostics. 2026;16(16):2608. doi:10.3390/diagnostics16162608

BibTeX
@article{Kim2026,
  author = {Kim, Jihye and Kim, You Ie and Kim, Sang Yong},
  title = {C-Reactive Protein-to-Albumin Ratio in Pediatric Inflammatory Bowel Disease: Associations with Disease Activity and Comparison with C-Reactive Protein Alone},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {16},
  pages = {2608},
  doi = {10.3390/diagnostics16162608}
}
Kostenlos starten →